Q2 EPS Forecast for Agilent Technologies Reduced by Analyst

Agilent Technologies, Inc. (NYSE:A - Free Report) - Leerink Partnrs cut their Q2 2025 EPS estimates for shares of Agilent Technologies in a research report issued on Wednesday, December 18th. Leerink Partnrs analyst P. Souda now forecasts that the medical research company will post earnings of $1.32 per share for the quarter, down from their previous estimate of $1.33. The consensus estimate for Agilent Technologies' current full-year earnings is $5.56 per share. Leerink Partnrs also issued estimates for Agilent Technologies' Q4 2025 earnings at $1.56 EPS and FY2027 earnings at $6.63 EPS.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Monday, November 25th. The medical research company reported $1.46 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.05. Agilent Technologies had a return on equity of 25.43% and a net margin of 19.80%. The company had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same quarter last year, the company posted $1.38 earnings per share. The business's quarterly revenue was up .8% compared to the same quarter last year.

A has been the subject of a number of other research reports. Stifel Nicolaus reiterated a "buy" rating and set a $151.00 price target on shares of Agilent Technologies in a research note on Monday, August 26th. StockNews.com lowered Agilent Technologies from a "buy" rating to a "hold" rating in a report on Tuesday, November 26th. Sanford C. Bernstein reduced their price objective on Agilent Technologies from $140.00 to $135.00 and set a "market perform" rating for the company in a research note on Tuesday, November 26th. Wells Fargo & Company lowered their target price on Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating on the stock in a research note on Monday, December 9th. Finally, JPMorgan Chase & Co. cut their price target on Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating for the company in a research note on Tuesday, November 26th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average price target of $143.62.

Agilent Technologies Stock Performance

Shares of A stock traded up $1.32 during trading hours on Friday, hitting $134.51. The stock had a trading volume of 4,342,841 shares, compared to its average volume of 1,736,894. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. The firm has a market capitalization of $38.65 billion, a PE ratio of 30.43, a PEG ratio of 4.48 and a beta of 1.07. The stock's 50 day moving average is $135.85 and its 200 day moving average is $136.44. Agilent Technologies has a twelve month low of $124.16 and a twelve month high of $155.35.

Agilent Technologies Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st will be issued a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date is Tuesday, December 31st. This is an increase from Agilent Technologies's previous quarterly dividend of $0.24. Agilent Technologies's dividend payout ratio (DPR) is currently 22.40%.

Insider Transactions at Agilent Technologies

In other news, SVP Dominique Grau sold 9,990 shares of the company's stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the transaction, the senior vice president now directly owns 40,011 shares of the company's stock, valued at approximately $5,801,595. This represents a 19.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.33% of the company's stock.

Institutional Investors Weigh In On Agilent Technologies

A number of institutional investors have recently added to or reduced their stakes in A. Menard Financial Group LLC increased its holdings in shares of Agilent Technologies by 1.6% in the second quarter. Menard Financial Group LLC now owns 4,845 shares of the medical research company's stock valued at $628,000 after buying an additional 77 shares in the last quarter. McAdam LLC raised its position in Agilent Technologies by 3.1% during the third quarter. McAdam LLC now owns 2,531 shares of the medical research company's stock valued at $376,000 after buying an additional 77 shares during the period. Brown Brothers Harriman & Co. grew its position in Agilent Technologies by 13.5% during the third quarter. Brown Brothers Harriman & Co. now owns 646 shares of the medical research company's stock valued at $96,000 after purchasing an additional 77 shares in the last quarter. Global Retirement Partners LLC lifted its position in Agilent Technologies by 3.2% in the 3rd quarter. Global Retirement Partners LLC now owns 2,570 shares of the medical research company's stock worth $382,000 after buying an additional 79 shares in the last quarter. Finally, Rovin Capital UT ADV boosted its stake in shares of Agilent Technologies by 1.6% during the 3rd quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company's stock valued at $750,000 after buying an additional 81 shares during the period. 87.42% of the stock is currently owned by institutional investors and hedge funds.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.